Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Slides:



Advertisements
Similar presentations
Tumor spectrum analysis in p53-mutant mice
Advertisements

Deletions of the INK4A Gene Occur in Malignant Peripheral Nerve Sheath Tumors but not in Neurofibromas  Helen P. Kourea, Irene Orlow, Bernd W. Scheithauer,
Vav‐1 gene‐targeting strategy.
Volume 93, Issue 3, Pages (May 1998)
Role of AP1/NFE2 binding sites in endogenous α-globin gene transcription by Melanie R. Loyd, Yasuhiro Okamoto, Mindy S. Randall, and Paul A. Ney Blood.
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization  A.M. Malfait, J.
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Volume 7, Issue 4, Pages (October 1997)
Volume 9, Issue 20, Pages S1-S2 (October 1999)
Analysis of the Human Ferrochelatase Promoter in Transgenic Mice
Volume 134, Issue 1, Pages (January 2008)
Late mitotic failure in mice lacking Sak, a polo-like kinase
Volume 15, Issue 1, Pages (July 2001)
Volume 8, Issue 6, Pages (December 2001)
Volume 5, Issue 4, Pages (October 1996)
Volume 11, Issue 4, Pages (October 1999)
Volume 9, Issue 4, Pages (October 1998)
The Mouse Spo11 Gene Is Required for Meiotic Chromosome Synapsis
Volume 1, Issue 1, Pages (February 2002)
Volume 9, Issue 3, Pages (September 1998)
Volume 154, Issue 6, Pages (September 2013)
Cdk2 Knockout Mice Are Viable
Generation of γ1 EQ conditional knock-in mice.
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 92, Issue 6, Pages (March 1998)
CD22 is a negative regulator of B-cell receptor signalling
Volume 91, Issue 1, Pages (October 1997)
Volume 18, Issue 2, Pages (April 2005)
Volume 91, Issue 5, Pages (November 1997)
Volume 97, Issue 4, Pages (May 1999)
Jung-Ok Han, Sharri B Steen, David B Roth  Molecular Cell 
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 8, Issue 5, Pages (February 1998)
Volume 153, Issue 4, Pages (May 2013)
Volume 6, Issue 2, Pages (August 2000)
Ahnak/Desmoyokin Is Dispensable for Proliferation, Differentiation, and Maintenance of Integrity in Mouse Epidermis  Michiyoshi Kouno, Gen Kondoh, Kyoji.
Volume 14, Issue 5, Pages (May 2001)
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Volume 2, Issue 3, Pages (September 2002)
Volume 10, Issue 6, Pages (December 2002)
Ludovica Bruno, Hans Jörg Fehling, Harald von Boehmer  Immunity 
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
Volume 17, Issue 4, Pages (October 2002)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice  Jie Zhu, Simone Petersen, Lino Tessarollo,
Volume 14, Issue 2, Pages (February 2001)
Volume 153, Issue 4, Pages (May 2013)
Volume 84, Issue 4, Pages (February 1996)
Volume 7, Issue 5, Pages (November 1997)
Ushio Takeda, Atsushi Utani, Jinghai Wu, Hiroshi Shinkai 
Volume 6, Issue 7, Pages (July 1996)
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 31, Issue 2, Pages (August 2009)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Volume 10, Issue 4, Pages (April 1999)
Fig. 4. Targeted disruption of STK35 transcripts in mouse.
Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts  Junjie Mei, Xingxu Huang, Pumin Zhang 
Volume 10, Issue 8, Pages (April 2000)
Volume 94, Issue 2, Pages (July 1998)
Volume 14, Issue 1, Pages (January 2001)
David A Schwarz, Carol D Katayama, Stephen M Hedrick  Immunity 
Volume 7, Issue 3, Pages (March 2005)
Volume 4, Issue 2, Pages (February 1996)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Volume 84, Issue 2, Pages (January 1996)
The tumor-suppressive functions of the human INK4A locus
Presentation transcript:

Role of the INK4a Locus in Tumor Suppression and Cell Mortality Manuel Serrano, Han-Woong Lee, Lynda Chin, Carlos Cordon-Cardo, David Beach, Ronald A DePinho  Cell  Volume 85, Issue 1, Pages 27-37 (April 1996) DOI: 10.1016/S0092-8674(00)81079-X

Figure 1 Disruption of the INK4a Locus in Mouse ES Cells and Generation of INK4a-Deficient Mice (A) Targeting strategy. The murine p16INK4a coding exons, E1α, E2 and E3, are indicated with closed boxes (Quelle et al. 1995b). The p19ARF-specific exon E1β is indicated with an open box (Quelle et al. 1995a) and has been placed upstream of exon E1α based on the location of human E1β (Duro et al. 1995; Stone et al. 1995a; Mao et al. 1995). Abbreviations for restriction endonucleases: P, PstI; S, SalI; Sc, SacI; N, NotI; Nh, NheI; B, BamHI; X, XbaI. The precise positions of two PstI sites in the 5′-region (2P) and one PstI site in the 3′-region (P) have not been determined. Homologous recombination replaces exons E2 and E3 with the pgk–neo cassette and introduces PstI and XbaI sites. (B) Southern blot of PstI-digested tail DNA from the offspring of INK4a+/− intercrosses. Probe A is a 1.3 kb BamHI fragment; probe B is a 0.4 kb PCR-generated probe corresponding to exons E2 and E3. Southern analysis of XbaI–digested genomic DNAs was consistent with the results obtained with PstI–digested DNAs (data not shown). PCR and Southern analysis indicated that the adjacent INK4b gene is present in INK4a-deficient mice. Similarly, the junction between the 5′ homologous region and the outside flanking sequence (around the SalI site) is also conserved in the INK4a-deficient mice. (C) Immunoprecipitation of p16INK4a, CDK4, and CDK6 complexes from MEFs. Cellular lysates were incubated with antibodies against p16INK4a, CDK4, or CDK6, in the absence or presence of appropriate competing peptides, as indicated. Cell 1996 85, 27-37DOI: (10.1016/S0092-8674(00)81079-X)

Figure 2 Survival Curves of INK4a-Deficient Mice in the Absence or Presence of Carcinogenic Treatments (A) Untreated and UVB-treated mice. (B) DMBA/UVB-treated mice. (C) DMBA-treated mice. In the INK4a−/− group, three mice developed clinically apparent tumors, and two mice died without clinically apparent tumors but could not be subjected to autopsy due to autolysis. In the INK4a+/− group, one mouse developed a tumor, and one mouse died but could not be subjected to autopsy due to autolysis. Cell 1996 85, 27-37DOI: (10.1016/S0092-8674(00)81079-X)

Figure 3 Histological Analysis of the Spontaneous Tumors Developed by INK4a−/− Mice (A–C) Photomicrographs of sections of a subcutaneous tumor processed as follows: (A) Hematoxylin and eosin staining. (B) Immunohistochemical staining against the melanocyte-marker protein S 100; positive staining corresponds to the section of a peripheral nerve. (C) Immunohistochemical staining against vimentin; the tumor and some invaded muscle fibers are stained. (D–F) Photomicrographs of sections of a lymph node processed as follows: (D) Hematoxylin and eosin staining. (E) Positive immunohistochemical surface staining against the leukocyte surface-marker CD45. (F) Positive immunohistochemical surface staining against the B cell surface-marker B220. Original magnification, 400×. Cell 1996 85, 27-37DOI: (10.1016/S0092-8674(00)81079-X)

Figure 4 Growth Properties of INK4a−/− Early-Passage MEFs (A) Growth curves of early-passage MEFs derived from individual embryos wt-8 (INK4a+/+), sko-12 (INK4a+/−) and dko-6 (INK4a−/−). The number of cells per 6 cm diameter dish is indicated. Similar results were obtained with cultures wt-5, wt-7, sko-1, and dko-9 (wt, INK4a+/+; sko, INK4a+/-; dko, INK4a−/−). (B) Analysis of cell cycle stages in exponentially growing cultures of INK4a+/+ and INK4a−/− MEFs derived from individual embryos. Cultures were labeled with anti-BrdU to detect DNA synthesis (vertical axis) and propidium iodide to detect total DNA (horizontal axis), and were analyzed by two-dimensional fluorescence-activated cell sorting (FACS). INK4a+/+ MEF cultures (wt-4 and wt-8) and INK4a−/− MEF cultures (dko-6 and dko-10) were analyzed. FACS profile for wt-8 and dko-10 are shown as an example. (C) Colony-formation efficiency of INK4a+/+ and INK4a−/− MEFs derived from individual embryos. Cell 1996 85, 27-37DOI: (10.1016/S0092-8674(00)81079-X)

Figure 5 Neoplastic Transformation of INK4a−/− Early-Passage MEFs with Ha-rasval12 (A) Foci-formation assay. Plates correspond to assay number 1 of Table 2. (B) Colony-formation assay in soft agar. Left, wt-8 (INK4a+/+) MEFs; middle, dko-6 (INK4a−/−) MEFs; right, cells from a focus produced by introduction of Ha-rasval12 into dko-6 (INK4a−/−) MEFs. Cells from 2 out of 3 randomly chosen dko-6/Ha-rasval12 foci were able to produce colonies in soft agar. Cell 1996 85, 27-37DOI: (10.1016/S0092-8674(00)81079-X)